MYO1B
Unconventional myosin-Ib
Also known as: MYO1B_HUMAN, myr1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43795
- Gene
- MYO1B
- Ensembl
- ENSG00000128641
- Chromosome
- 2
- Canonical length
- 1136 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Enables ATP binding activity; actin filament binding activity; and microfilament motor activity. Involved in actin filament organization and post-Golgi vesicle-mediated transport. Located in several cellular components, including actin filament; endosome; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1136 residues, UniProt reviewed canonical sequence.
>O43795|MYO1B
1 MAKMEVKTSL LDNMIGVGDM VLLEPLNEET FINNLKKRFD HSEIYTYIGS VVISVNPYRS
61 LPIYSPEKVE EYRNRNFYEL SPHIFALSDE AYRSLRDQDK DQCILITGES GAGKTEASKL
121 VMSYVAAVCG KGAEVNQVKE QLLQSNPVLE AFGNAKTVRN DNSSRFGKYM DIEFDFKGDP
181 LGGVISNYLL EKSRVVKQPR GERNFHVFYQ LLSGASEELL NKLKLERDFS RYNYLSLDSA
241 KVNGVDDAAN FRTVRNAMQI VGFMDHEAES VLAVVAAVLK LGNIEFKPES RVNGLDESKI
301 KDKNELKEIC ELTGIDQSVL ERAFSFRTVE AKQEKVSTTL NVAQAYYARD ALAKNLYSRL
361 FSWLVNRINE SIKAQTKVRK KVMGVLDIYG FEIFEDNSFE QFIINYCNEK LQQIFIELTL
421 KEEQEEYIRE DIEWTHIDYF NNAIICDLIE NNTNGILAML DEECLRPGTV TDETFLEKLN
481 QVCATHQHFE SRMSKCSRFL NDTSLPHSCF RIQHYAGKVL YQVEGFVDKN NDLLYRDLSQ
541 AMWKASHALI KSLFPEGNPA KINLKRPPTA GSQFKASVAT LMKNLQTKNP NYIRCIKPND
601 KKAAHIFNEA LVCHQIRYLG LLENVRVRRA GYAFRQAYEP CLERYKMLCK QTWPHWKGPA
661 RSGVEVLFNE LEIPVEEYSF GRSKIFIRNP RTLFKLEDLR KQRLEDLATL IQKIYRGWKC
721 RTHFLLMKKS QIVIAAWYRR YAQQKRYQQT KSSALVIQSY IRGWKARKIL RELKHQKRCK
781 EAVTTIAAYW HGTQARRELR RLKEEARNKH AIAVIWAYWL GSKARRELKR LKEEARRKHA
841 VAVIWAYWLG LKVRREYRKF FRANAGKKIY EFTLQRIVQK YFLEMKNKMP SLSPIDKNWP
901 SRPYLFLDST HKELKRIFHL WRCKKYRDQF TDQQKLIYEE KLEASELFKD KKALYPSSVG
961 QPFQGAYLEI NKNPKYKKLK DAIEEKIIIA EVVNKINRAN GKSTSRIFLL TNNNLLLADQ
1021 KSGQIKSEVP LVDVTKVSMS SQNDGFFAVH LKEGSEAASK GDFLFSSDHL IEMATKLYRT
1081 TLSQTKQKLN IEISDEFLVQ FRQDKVCVKF IQGNQKNGSV PTCKRKNNRL LEVAVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYO1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 239 nTPM
Expression across tissuesHPA
Tissue
- liver: 239 nTPM
- lung: 71 nTPM
- pancreas: 47 nTPM
- placenta: 46 nTPM
- adipose tissue: 40 nTPM
- parathyroid gland: 33 nTPM
Single-cell type
- hepatocytes: 807 nCPM
- podocytes: 772 nCPM
- pericytes: 639 nCPM
- alveolar cells type 1: 593 nCPM
- renal connecting tubule cells: 492 nCPM
- tuft cells: 461 nCPM
Immune cell
- memory B-cell: 0.5 nTPM
- naive B-cell: 0.5 nTPM
- naive CD4 T-cell: 0.2 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- thalamus: 30 nTPM
- amygdala: 21 nTPM
- cerebral cortex: 21 nTPM
- midbrain: 20 nTPM
- basal ganglia: 18 nTPM
- white matter: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYO1B.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 150 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on MYO1B was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.43
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament bundle assembly
- actin filament organization
- actin filament-based movement
- endocytosis
- post-Golgi vesicle-mediated transport
Molecular functions
- actin filament binding
- ATP binding
- cadherin binding
- calmodulin binding
- microfilament motor activity
- phosphatidylinositol-3,4,5-trisphosphate binding
- phosphatidylinositol-4,5-bisphosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- IQ motif, EF-hand binding site
- Myosin head, motor domain-like
- Class I myosin tail homology domain
- P-loop containing nucleoside triphosphate hydrolase
- Class I myosin, motor domain
- Kinesin motor domain superfamily
- Myosin head (motor domain)
- IQ calmodulin-binding motif
- Unconventional myosin tail, actin- and lipid-binding
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYO1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYO1B as an antibody target. Whether an autoantibody or antibody against MYO1B could matter depends on whether native MYO1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYO1B is annotated at the cell surface, where native MYO1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MYO1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...